HCA
GMAB icon

Harbour Capital Advisors’s Genmab GMAB Stock Holding History

Harbour Capital Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7,168
Closed -$253K – 277
2023
Q3 		$253K Hold
7,168
– – 0.08% 225
2023
Q2 		$274K Buy
7,168
+490
+7% +$19.5K 0.08% 210
2023
Q1 		$252K Buy
6,678
+225
+3% +$8.65K 0.08% 221
2022
Q4 		$278K Buy
+6,453
New +$266K 0.09% 188

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Harbour Capital Advisors's GMAB Position: Q4 2023 in Review

Harbour Capital Advisors sold out of Genmab (GMAB) in Q4 2023, closing a stake of 7,168 shares — an estimated $253K sold.

Harbour Capital Advisors first reported a position in GMAB in Q4 2022 and held it in 4 quarters. The position peaked at $278K in Q4 2022. 225 funds tracked by Wall St. Rank hold GMAB as of Q4 2023.

  • Harbour Capital Advisors reported no remaining Genmab position as of Q4 2023 after selling out during the quarter.
  • Harbour Capital Advisors sold 7,168 Genmab shares in Q4 2023, an estimated $253K.
  • Harbour Capital Advisors first reported a position in Genmab in Q4 2022 and held it in 4 quarters.
  • Harbour Capital Advisors's Genmab position peaked at $278K in Q4 2022.
  • 225 funds tracked by Wall St. Rank held Genmab as of Q4 2023.

Based on Harbour Capital Advisors's 13F filing for Q4 2023, filed 5 Jan 2024.